# US 2014/0271913 A1 · Compositions and methods for manufacturing sol-gel derived bioactive borophosphate glasses for medical applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0271913 A1
- Document ID: US20140271913A1
- Status: Published application
- Kind: A1
- Application number: 14/204,839
- Filed: 2014-03-11
- Published: 2014-09-18
- Earliest claimed: 2013-03-14
- Inventors: Gregory J. Pomrink; Zehra Tosun; Cecilia Cao; Roy Layne Howell
- Web page: https://patentgrep.com/patent/US20140271913A1

## CPC

- A61K 33/42: Phosphorus; Compounds thereof
- A61K 33/08: Oxides; Hydroxides
- A61K 33/22: Boron compounds
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A61L 27/10: Ceramics or glasses
- A61L 27/52: Hydrogels or hydrocolloids
- C03C 3/19: containing boron
- C03C 4/0007: {for biologically-compatible glass}
- A61L 2400/04: Materials for stopping bleeding
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- C03C 2203/26: using alkoxides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C03C: CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS

## Abstract

A sol-gel bioactive glass precursor, method for making sol-gel glasses, resultant sol-gel bioactive glasses, and methods of use thereof which include at least 5 weight percent CaO, at least 10 weight percent P2O5, at least 10 weight percent Na2O, and at least 25 weight percent B2O3, wherein the bioactive glass is substantially silica-free. Medical and industrial uses of such glasses.

## Claims

### Claim 1

A sol-gel derived bioactive glass composition, wherein the bioactive glass is at least 5 weight percent CaO, at least 10 weight percent P2O5, at least 10 weight percent Na2O, and at least 25 weight percent B2O3, wherein the bioactive glass is substantially silica-free.

### Claim 2 (depends on 1)

The sol gel derived bioactive glass composition of claim 1, wherein the bioactive glass has a granular form, particulate form, matt form, fiber form, hemostatic sponge form, foam form, paste or putty form, or sphere or bead form, or a combination thereof.

### Claim 3

A sol-gel bioactive glass precursor including a source of Ca, P, Na, and B wherein the sol-gel bioactive glass precursor is substantially Si free.

### Claim 4 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the B source is triisopropyl borate.

### Claim 5 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the Ca source is calcium methoxymethoxide.

### Claim 6 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the P source is triethylphosphate.

### Claim 7 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the Na source is NaCl.

### Claim 8 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the Na source is C2H5ONa.

### Claim 9 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the source of Na is NaCl and is present in an amount to provide for 20-30% by weight of Na2O in a sol-gel bioactive glass.

### Claim 10 (depends on 3)

The sol-gel bioactive glass precursor of claim 3, wherein the source of Na is C2H5ONa and is present in an amount to provide for 20-30% by weight of Na2O in a sol-gel bioactive glass.

### Claim 11 (depends on 3)

The sol gel bioactive glass precursor of claim 3, wherein the source of phosphate is triethylphosphate and is present in an amount to provide for 20-30% by weight of P2O5 in a sol-gel bioactive glass.

### Claim 12

A method of making a sol-gel bioactive glass, wherein the bioactive glass is at least 5 weight percent CaO, at least 10 weight percent P2O5, at least 10 weight percent Na2O, and at least 25 weight percent B2O3, wherein the bioactive glass is substantially silica-free comprising:
mixing a sol-gel bioactive glass precursor including a source of B, Ca, P, and Na;
aging the mixture, and;
drying the mixture to form the sol-gel bioactive glass.

### Claim 13 (depends on 12)

The method of claim 12, wherein the B source is triisopropyl borate.

### Claim 14 (depends on 12)

The method of claim 12, wherein the Ca source is calcium methoxymethoxide.

### Claim 15 (depends on 12)

The method of claim 12, wherein the P source is triethylphosphate.

### Claim 16 (depends on 12)

The method of claim 12, wherein the Na source is NaCl.

### Claim 17 (depends on 12)

The method of claim 12, wherein the Na source is C2H5ONa.

### Claim 18 (depends on 12)

The method of claim 12, wherein said aging is conducted at a temperature of 50-80° C. for 40-70 hours.

### Claim 19 (depends on 12)

The method of claim 12, wherein said drying is conducted at 400-600° C. for 15 to 50 hours.

### Claim 20 (depends on 1)

A method for achieving hemostasis in a patient in need of treatment thereof comprising contacting the patient with the sol-gel bioactive glass of claim 1.

### Claim 21 (depends on 1)

A method of inducing rapid coagulation in a bleeding patient comprising contacting the patient with the sol-gel bioactive glass of claim 1.

### Claim 22 (depends on 3)

A method for achieving hemostasis in a patient in need of treatment thereof comprising contacting the patient with a sol-gel bioactive glass made from the sol-gel bioactive glass precursor of claim 3.

### Claim 23 (depends on 1)

The sol-gel derived bioactive glass composition of claim 1, further comprising an extracellular matrix protein.

### Claim 24 (depends on 1)

A method of treating a wound comprising applying the sol-gel derived bioactive glass composition of claim 1 to the wound, wherein the sol-gel derived bioactive glass composition releases ions into the wound.

### Claim 25 (depends on 1)

A method of stimulating osteoblast differentiation comprising contacting an osteoblast with the sol-gel derived bioactive glass composition of claim 1, wherein the sol-gel derived bioactive glass composition releases ions and the method is effective to induce osteoblast differentiation.

### Claim 26 (depends on 1)

A method of stimulating osteoblast proliferation comprising contacting an osteoblast with the sol-gel derived bioactive glass composition of claim 1, wherein the sol-gel derived bioactive glass composition releases ions and the method is effective to induce osteoblast proliferation.

### Claim 27 (depends on 1)

A method of repairing bone defects comprising contacting bone in need of treatment thereof with the sol-gel bioactive glass of claim 1.

### Claim 28

A sol-gel derived bioactive glass composition, wherein the bioactive glass is at least 5 weight percent alkaline earth metal, at least 10 weight percent P2O5, at least 10 weight percent alkali metal, and at least 25 weight percent B2O3, wherein the bioactive glass is substantially silica-free.

### Claim 29 (depends on 28)

The sol-gel derived bioactive glass composition of claim 28, wherein the alkali metal is selected from the group consisting of Na, Li, or K.

### Claim 30 (depends on 28)

The sol-gel derived bioactive glass composition of claim 28, wherein the alkaline earth metal is selected from the group consisting of Ca, Mg, Sr or Ba.

### Claim 31 (depends on 28)

The sol gel derived bioactive glass composition of claim 28, wherein the bioactive glass has a granular form, particulate form, matt form, fiber form, hemostatic sponge form, foam form, paste or putty form, or sphere or bead form, or a combination thereof.

### Claim 32

A method of making a sol-gel bioactive glass including Si, Ca, P, and Na comprising:
mixing a sol-gel bioactive glass precursor including a source of Si, Ca, P, and Na, wherein the sodium source is selected from the group consisting of NaCl and C2H5ONa, and;
drying the mixture at a temperature of 100° C. or lower.

### Claim 33 (depends on 32)

The method of claim 32, further comprising adding a biologically active molecule.

### Claim 34

A method of making a sol-gel bioactive glass, wherein the bioactive glass is at least 5 weight percent CaO, at least 5 weight percent P2O5, at least 10 weight percent Na2O, and at least 25 weight percent B2O3, wherein the bioactive glass is substantially silica-free comprising:
mixing a sol-gel bioactive glass precursor including a source of B, Ca, P, and Na;
aging the mixture, and;
drying the mixture to form the sol-gel bioactive glass.
